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Abstract
The use of open-source programming languages, such as R, in health decision sciences is growing and has the potential to 
facilitate model transparency, reproducibility, and shareability. However, realizing this potential can be challenging. Models 
are complex and primarily built to answer a research question, with model sharing and transparency relegated to being sec-
ondary goals. Consequently, code is often neither well documented nor systematically organized in a comprehensible and 
shareable approach. Moreover, many decision modelers are not formally trained in computer programming and may lack 
good coding practices, further compounding the problem of model transparency. To address these challenges, we propose 
a high-level framework for model-based decision and cost-effectiveness analyses (CEA) in R. The proposed framework 
consists of a conceptual, modular structure and coding recommendations for the implementation of model-based decision 
analyses in R. This framework defines a set of common decision model elements divided into five components: (1) model 
inputs, (2) decision model implementation, (3) model calibration, (4) model validation, and (5) analysis. The first four 
components form the model development phase. The analysis component is the application of the fully developed decision 
model to answer the policy or the research question of interest, assess decision uncertainty, and/or to determine the value of 
future research through value of information (VOI) analysis. In this framework, we also make recommendations for good 
coding practices specific to decision modeling, such as file organization and variable naming conventions. We showcase 
the framework through a fully functional, testbed decision model, which is hosted on GitHub for free download and easy 
adaptation to other applications. The use of this framework in decision modeling will improve code readability and model 
sharing, paving the way to an ideal, open-source world.
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1 Introduction
Many journals now strongly encourage that the data and 
the code underlying an analysis be archived and made pub-
licly available alongside the publication [1, 2]. There are 
similar calls for making mathematical models that are the 
basis for health technology assessments (HTAs) and cost-
effectiveness analyses (CEAs) available to promote trans-
parency, support reproducibility, and facilitate adaptation of 
existing models to new applications [3, 4]. In formal HTA 
submissions, it is already expected that the model itself will 
be provided to clients and stakeholders for them to scru-
tinize and manipulate, necessitating a certain degree of 
model transparency and usability [5, 6]. More broadly, the 
Open-Source Model Clearinghouse was recently launched 
as a database of open source models with a mandate to, in 
part, “facilitate adherence to standards calling for open dis-
closure of scientific software” [7]. Though it has been com-
mon wisdom that a detailed methods section and a lengthy 
appendix of equations should be sufficient to reproduce a 
mathematical model, this is not generally the case. Thus, to 
support the transparency of mathematical modeling, more 
and more emphasis is being placed on sharing the underlying 
model construction, be it implemented in a specific software 
platform or coded in a programming language [8–10].
For anyone who has ever looked under the hood of soft-
ware source code, the naivety of transparency being achieved 
by sharing such code is obvious. Even for a well-trained and 
sophisticated programmer, coding entails a certain amount 
of personal style and preferences which may or may not be 
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Key Points for Decision Makers 
The use of open-source software for model-based cost-
effectiveness analyses is growing and has the potential 
to facilitate model transparency, reproducibility, and 
shareability. However, guidance as to how to structure 
the required components of such analyses is lacking.
A high-level coding framework can help standardize 
the construction of model-based decision and cost-
effectiveness analyses, allowing the model code to be 
more easily read, scrutinized, and understood by others. 
The Decision Analysis in R for Technologies in Health 
(DARTH) framework modularizes decision models into 
a set of core components and provides guidance on how 
to structure and organize the implementation of these 
commons in R.
Adoption of this general framework will facilitate the 
sharing and readability of decision models implemented 
in R. It will also support the broader use of R in formal 
health technology assessment (HTA) submissions, allow-
ing for more complex modeling methods to be more 
transparently incorporated into decision making.
modeling so that these models can be read, scrutinized, and 
understood by their consumers.
The aim of this paper is to provide a high-level framework 
that sets a common structure for decision-model building for 
both model developers and model consumers. The develop-
ment of this framework is the culmination of the research 
and pedagogical experiences of The Decision Analysis in 
R for Technologies in Health (DARTH) workgroup [12]. 
The DARTH framework modularizes decision models into 
a set of core components that are common across CEAs and 
HTA submissions, regardless of the type of mathematical 
model used. In this paper, we also provide a number of rec-
ommendations specific to decision-modeling applications 
relating to file organization, variable naming conventions, 
use of functions and data structures, and unit testing. How-
ever, these more detailed recommendations are suggestions 
only; the primary purpose of the DARTH framework is to 
outline a high-level organizational structure for code under-
lying a decision-modeling analysis. Given the diversity of 
applications and methodological needs of different analyses, 
we hope that the DARTH framework provides a scaffolding 
to facilitate readability, usability, and reproducibility of the 
analysis to others, without overly restricting the kinds of 
models and analyses that can be implemented in this frame-
work. We showcase the DARTH framework through a fully 
functional, testbed decision model developed in R [11, 13], 
implemented as an R package (darthpack) that is freely 
available for download via GitHub (https ://githu b.com/
DARTH -git/darth pack). The testbed model was designed to 
serve as a template for organizing and sharing model and 
analysis source code [14] that can be easily adapted to other 
applications and enhanced by other decision modelers. The 
adoption and promotion of this framework will create more 
readable, and thus more shareable models, paving the way to 
an open-source culture in health decision sciences.
2  Methods
2.1  Components of a Decision Model
The DARTH framework is based on the premise that a com-
prehensive model-based decision and/or CEA will involve 
the same high-level model-development analysis compo-
nents, regardless of the specific structure of the decision 
model being applied, be it a decision tree, Markov model, 
stochastic simulation model, and so on. In developing this 
framework, we strived to create a flexible framework that 
can successfully organize code relating to a diversity of 
model types and applications.
The framework we present here focuses on the organiza-
tion of R code for the conduct of a decision analysis, but not 
on the specific content of the code within each component. 
intuitive to the reader. Imagine, then, the even more extreme, 
yet still common, situation of releasing code that was never 
intended for public use to the public. If this is done as an 
after-thought, documentation may be lacking, and the code 
structure will likely be a byproduct of the complex deci-
sion history that it took to arrive at the final model structure 
rather than a pre-planned organizational structure. All these 
issues may be further obscured when proprietary software is 
required to view/operate the model, which may limit access 
to those with active licenses and installations. The appeal 
of proprietary software is often in the facilitation of model 
construction through a graphical interface that allows a user 
to point-and-click their way through an analysis. However, 
despite the initial user-friendliness of these software plat-
forms, sharing the model alone still does not necessarily 
achieve transparency or reproducibility, as any manual point-
and-click steps are not captured or recorded [11].
Health decision science and HTA are fields situated at 
the intersection of operations research, economics, statis-
tics, medicine, and public health. Computer science and 
software development are generally not the major foci of 
decision-analytic training, as models are used to answer spe-
cific research questions, not necessarily as general tools for 
a client user-base. Thus, in order for the benefits of transpar-
ent and open model sharing to be fully realized, guidance 
is needed on coding best practices as they relate to decision 
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We also assume that an analyst has already fully documented 
their biological, behavioral, and mathematical assumptions 
and decisions that went into their model and analysis in 
some kind of technical appendix. In our case study, we pro-
vide an example of how such documentation might look, but 
it is not the primary focus of this work. Thus, commentary in 
the code will primarily explain the functionality of that code, 
with the assumption that broader descriptions of the disease 
processes, interventions, and policy questions are provided 
alongside the code in a separate document.
The DARTH framework divides a decision analysis 
into five components: (1) model inputs, (2) decision model 
implementation, (3) model calibration, (4) model valida-
tion, and (5) analysis. The first four components form the 
model development phase, whereas the analysis component 
is the application of the final model to answer the policy or 
research question of interest, assess decision uncertainty, 
and/or to determine the value of future research through 
value of information (VOI) analysis. The same model from 
the development phase could be used to answer multiple 
research questions, which is why we make this distinction. 
The relationship between the five components is illustrated 
in Fig. 1 and described in detail in the sections that follow.
2.1.1  Component 1: Define Model Inputs
In this component, all model input variables are declared 
and values are set. We broadly categorize input variables 
into three categories depending on how their values are 
informed: external, estimated, and calibrated. Parameters 
informed by external sources are set to a value either directly 
into an R script or read in from an external source, such 
as a .csv file or a data repository. These parameter values 
(and uncertainty ranges and distributions for probabilistic 
analyses) are derived from published literature or external 
data analyses not embedded into the analysis itself. Esti-
mated parameters are those whose values are estimated 
through a primary data analysis conducted within the deci-
sion analysis. R has the advantage of being both a statistical 
and a programming environment. This allows any neces-
sary statistical analyses to be embedded directly within the 
decision analysis, further improving analysis transparency 
and reproducibility. The third type of model parameters are 
those that will be estimated via model calibration. In this 
first stage of the DARTH framework, we simply set these 
parameters to some valid but arbitrary ‘dummy’ values that 
are compatible with the next phase of the analysis—model 
implementation—but are ultimately just placeholder values 
until we conduct the calibration phase. Not all models will 
utilize all three types of input variables and different mod-
els may rely more heavily on one input type than another. 
While we selected the three input parameter categories based 
on how models are typically parameterized, for any given 
application, it may make sense to organize input parameters 
according to a different set of categories. The point of this 
component is to group input variables together and organize 
them in a logical fashion that can be easily communicated to 
a user rather than rigidly prescribe a universal input param-
eter organizational structure.
2.1.2  Component 2: Decision Model Implementation
This implementation of the decision model component 
is the heart of the decision analysis. In this section of the 
DARTH framework, a function that maps model inputs to 
outputs is created, via the dynamic and/or stochastic pro-
cesses that the decision model represents. The model itself 
could be a decision tree, Markov model, stochastic simula-
tion, and so on. The output stored from the model at this 
stage should be sufficiently general and comprehensive to 
accommodate calibration, validation, and the main policy 
analysis. Constructing the model as a function at this stage 
facilitates subsequent components of model development 
and analysis, as these processes will all call the same model 
function but pass different parameter values and/or calculate 
different final outcomes from the model outputs. The model 
function also facilitates the use of parallel computing efforts 
for computationally intensive tasks, such as calibration and 
probabilistic sensitivity analysis (PSA).
We should note explicitly that the model function created 
here should have the capacity to capture the effect of any 
interventions or policy scenarios of interest on the outcomes 
of interest. The specific ways that intervention effects are 
incorporated into the model are decisions for the analyst. 
Interventions that reflect changing intensities of existing pro-
cesses (e.g., increasing the frequency of screening) may be 
implemented by changing the values of relevant model input 
parameters. However, it is often the case that different inter-
ventions enable completely different pathways and processes 
in the model (e.g., medical management vs surgery) and 
would be better captured by passing a categorical parameter 
value that indicates the intervention to be simulated. We do 
not recommend mixing these two cases and generally rec-
ommend using an explicit categorical intervention variable 
for generalizability. Ultimately, the analyst should decide 
how best to implement the functionality required for their 
application.
2.1.3  Component 3: Model Calibration
In the model calibration component, unknown or highly 
uncertain model parameters are estimated by calibrating 
model outputs to match specified calibration targets [15–17]. 
This component involves both the setup of the calibration 
(specification of plausible ranges or prior distributions for 
input parameters to be calibrated, specification of calibration 
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targets, calculation of corresponding values from model out-
puts, and assessment of fit to targets) as well as carrying out 
the calibration itself with a chosen algorithm. Once appro-
priate values, ranges, and/or distributions have been identi-
fied for calibrated parameters, these values will replace the 
placeholder values established in the model inputs compo-
nent for the subsequent validation and analysis components. 
Though rare, not all models will have parameters that need 
to be calibrated. In such cases, the model calibration com-
ponent can simply be omitted.
2.1.4  Component 4: Validation
Model validation should at the very least demonstrate the 
internal validity of the model. This means that the model 
reproduces outputs that correspond to its inputs [3, 18]. For 
example, if an input parameter to the model was set to reflect 
a screening frequency of every 2 years, then the number of 
screenings conducted in the population over a given period 
of time should correspond to an average per-person screen-
ing frequency of every 2 years. Internal validity may also be 
demonstrated by plotting model-predicted outputs against 
calibration targets. Additionally, comparison of model out-
puts to other data sources not used in the model development 
(external validation) or to other models (comparative valid-
ity) may also be conducted here [19–23].
2.1.5  Component 5: Analysis
The analysis component is where the model developed in 
components 1–4 is applied to answer the question(s) of inter-
est given current information. An analysis will generally be 
broken down into several subcomponents. As an example, 
we describe an analysis with three subcomponents: a prob-
abilistic analysis (which includes the base-case analysis), 
a deterministic scenario and sensitivity analysis (such as 
one- and two-way sensitivity analyses), and a VOI analysis. 
However, in any given analysis, the analyst should create 
subcomponents that are relevant and appropriate for their 
application. Though the purposes and the structure of our 
example subcomponents vary, the general setup is similar. 
First, the analyst must specify the input parameter values 
that should be passed to the decision model function. Sec-
ond, the analyst must set up calculation of the desired out-
put values from the decision model outputs, which again 
are more comprehensive and detailed than may be neces-
sary. For example, a Markov cohort model might output the 
cohort trace (distribution of the cohort across health states 
over the time horizon) or the transition dynamics array 
(proportion of the cohort that transitioned between any two 
health states in each cycle over the time horizon) [24], but 
in a given analysis, perhaps only the cohort’s survival over 
time is of interest. Within CEA in particular, there are many 
Fig. 1  Schematic representation of the connectivity between the different components of the proposed DARTH framework
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standard calculations, comparisons, and visualizations that 
are conducted based only on the total costs and quality-
adjusted life-years (QALYs) calculated from model outputs 
for a set of strategies.
2.1.6  Subcomponent 5a: Probabilistic Analysis
The probabilistic analysis subcomponent is the primary 
analysis component in the DARTH framework, which is 
typical for CEA following the recent guidance from the Sec-
ond Panel on Cost-Effectiveness in Health and Medicine 
and satisfying the requirements of many HTA agencies [6, 
25]. In a probabilistic analysis, also called a probabilistic 
sensitivity analysis (PSA), sets of input parameter values are 
randomly sampled from specified distributions. The model 
is then run for each set of parameter values, producing cor-
responding model outputs. Using analyst-specified func-
tions that calculate outcomes of interest based on the model 
function output, means and standard deviations of these out-
comes can be calculated from the PSA samples. For CEAs, 
primary outcomes of interest are generally total discounted 
costs and QALYs accrued over the analysis time horizon, 
though other intermediate outcomes may also be of interest. 
Interventions are then compared by calculating incremental 
cost-effectiveness ratios (ICERs) based on the expected cost 
and QALY outcomes from the PSA. We note that in the 
past, a primary analysis was often conducted using a sin-
gle, deterministic set of base-case parameter values but this 
practice is no longer recommended [6]. The distributions of 
outcomes produced from the PSA are also used to produce 
additional results regarding decision uncertainty, including 
cost-effectiveness acceptability curves (CEACs) and frontier 
(CEAF), expected loss curves (ELCs), and others [26]. For 
these common procedures, we rely on the decision-analytic 
modeling in R package, dampack, which is available for 
download from https ://githu b.com/DARTH -git/dampa ck. 
Instructions for installing dampack are described in the 
dampack GitHub repository.
2.1.7  Subcomponent 5b: Scenario and Deterministic 
Sensitivity Analysis
The scenario and deterministic sensitivity analysis subcom-
ponent is where the impact of individual or pairs of param-
eters on model outcomes can be assessed systematically 
through one- and two-way sensitivity analyses. An analyst 
may also wish to compare different scenarios (e.g., high- vs 
low-cost scenarios), either in a probabilistic or deterministic 
framing. Generally, these scenario analyses and sensitivity 
analyses would be secondary to the primary results pre-
sented in subcomponent 5a.
2.1.8  Subcomponent 5c: Value of Information (VOI) 
Analysis
In the VOI component, we determine whether further poten-
tial research is needed using the results from the PSA gener-
ated in the probabilistic analysis subcomponent. The most 
common VOI measures are the expected value of perfect 
information (EVPI), the expected value of partial perfect 
information (EVPPI), the expected value of sample infor-
mation (EVSI) [27, 28], and, more recently, the curve of 
optimal sample size (COSS) [29].
2.2  File Structure and Organization
A model implemented in the R programming environment 
will involve a series of scripts with the file extension ‘.R’. 
The analysis will also generally use and/or generate a num-
ber of data and output files, which may be either stored as 
internal R data files (using ‘.RData’, ‘.rda’, or ‘.rds’ exten-
sions) or as external data files, such as comma-separated-val-
ues (‘.csv’) files. In the suggested organizational file struc-
ture of the DARTH framework, we use folders to delineate 
the different purposes that these files serve in the analysis. 
Within a folder, we append the relevant component number 
to the beginning of each file name to indicate where the file 
will be used or was created (in the case of outputs). Our 
suggested folder structure is summarized in Table 1. This 
structure is inspired by the organizational recommendations 
for an R package [30] and a simple reproducible workflow 
developed in the field of ecology and evolution [31]. As an 
example, consider the ‘data-raw’ folder. The purpose of this 
folder is to store the raw data files that will be cleaned, pro-
cessed, and/or analyzed to be used as inputs in the different 
components. The processed data would then be placed in the 
‘data’ folder, perhaps stored as the file ‘01_primary_data.
RData’ to indicate that it will inform model parameter val-
ues (the first framework component). Within this folder, we 
would likely also have a file named ‘01_inputs.csv’, which 
would contain model parameter values derived externally 
from published literature. Finally, in addition to input data 
for the input generation component, an analyst might also 
have a ‘03_calibration_targets.RData’ that stores the calibra-
tion target data that will be used to estimate unknown model 
parameters through calibration.
Our suggested file folder structure is fairly self-explana-
tory and certainly customizable. However, two folders that 
warrant further clarification are the ‘R’ and ‘analysis’ fold-
ers. The ‘R’ folder is the traditional directory for storing 
functions for an R package. Here, we store a separate ‘.R’ 
script with all the functions for each framework component 
as well as some auxiliary ‘.R’ scripts, such as the description 
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of the different data included in the R package. For exam-
ple, the ‘data_init_params.R’ script includes the description 
of the initial set of base-case parameters. To document the 
functions and processed data to be used as package data, 
we used roxygen2. roxygen2 is the recommended 
format to produce documentation for R packages. For a 
more detailed description on the different components and 
steps for building an R package, we refer the reader to the 
R package book by Wickham [30]. Formalizing operations 
into functions is especially advantageous for operations that 
will be repeated (e.g., calculation of total costs and QALYs 
from model output). A single function can replace multiple 
lines of code and modularizes operations, and any updates 
to these repeated operations will be propagated across all 
function calls. Using functions is considered a good pro-
gramming practice [32]. Functions that are customized for 
the particular application, model, and/or analysis should 
be defined in the ‘.R’ file corresponding to the component 
where they are first needed. For example, the decision model 
is implemented as a function, which is important since it will 
be called by so many other processes (calibration, valida-
tion, as well as the analysis components). Model calibra-
tion would also involve several custom functions, such as 
functions to derive outputs corresponding to the calibra-
tion targets from the model’s more generic, full output and 
functions to compare those model outputs to the calibration 
target values in terms of some kind of measure of ‘fit’. The 
analysis components will have many functions for calculat-
ing outputs of interests (e.g., aggregating costs and QALYs 
over a time horizon of interest), and running the model over 
different sets of input parameter values in deterministic and 
probabilistic sensitivity analyses.
The ‘analysis’ folder is the traditional directory for stor-
ing the scripts with the code of R-based analyses. In this 
folder, we store a ‘.R’ script for each framework component. 
These scripts are the overall control for these processes.
Table 1  File folder structure for organizing model and analysis files used in the proposed DARTH coding framework
CEA cost-effectiveness analysis, HTA health technology assessment, ICERs incremental cost-effectiveness ratios, PSA probabilistic sensitivity 
analysis
Folder name Folder function
data-raw This is where raw data is stored alongside ‘.R’ scripts that read in raw data, process these data, and call use_this::use_
data (<processed data>) to save .rda formatted data files in the ‘data’ folder. These data could include a ‘.csv’ file with input 
parameters derived from the published literature, as well as internal R data files (with .RData, .rds, or .rda extensions) containing 
primary data from which model input values will be estimated through statistical models embedded into the analysis
data This is where input data is stored to be used in the different components of the CEA. These data could be generated from raw data 
stored in the ‘data-raw’ folder. Essentially, this folder stores the cleaned or processed versions of raw data that has been gathered 
from elsewhere
R This is where ‘.R’ files that define functions to be used as part of the analysis are stored. These are functions that are specific to 
the analysis. The model will be one such function; however, other functions will likely be used, such as computing the fit of the 
model output to the specific calibration targets of the analysis. This folder also stores ‘.R’ scripts that document the datasets in 
the ‘data’ folder
analysis This is where interactive scripts of the analysis would be stored. These scripts control the overall flow of the analysis. This is also 
where many operations that ultimately become functions will be developed and debugged
output This is where output files of the analysis would be stored. These files may be internal R data files (‘.RData’, ‘.rds’, ‘.rda’) or 
external data files (such as ‘.csv’). Examples of files stored here would be the output of the model calibration component or the 
PSA dataset generated in the uncertainty analysis component. These data files can then be loaded by other components without 
having to first rerun previous components (e.g., the calibrated model values can be loaded for a base-case analysis without re-
running the calibration)
figs For analyses that will include figures, we generally create a separate figures folder. Though these could be stored in the output 
folder, it can be helpful to have a separate folder so that the images of the figure files can be easily previewed. This is particularly 
important for analyses that generate a large number of figures
tables This folder includes tables to be included in a publication or report, such as the table of intervention costs and effects and ICERs
report A report folder could be used to store R Markdown files to describe in detail the model-based CEA by using all the functions and 
data of the framework, run analyses and display figures. The R Markdown files can be compiled into .html, .doc or .pdf files to 
generate a report of the CEA. This report could be the document submitted to HTA agencies accompanying the R code of the 
model-based CEA
vignettes A vignettes folder could be used to describe the usage of the functions and data of each of some or all components of the frame-
work through accompanying R Markdown files as documentation. The R Markdown file can use all the functions, outputs, and 
figures to integrate the R code into the Markdown text
tests A tests folder includes ‘.R’ scripts that run all the unit tests of the functions in the framework. A good practice is to have one file 
of tests for each complicated function or for each of the components of the framework
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2.3  Naming Conventions
Within the outlined file structures, we recommend that 
analysts use a consistent naming convention for variables 
and files throughout their code that balance readability and 
brevity. Different well thought-out naming conventions have 
been proposed, including coding styles recommended by the 
tidyverse collection of R packages [33] and the Google R 
Style Guide [34]. We summarize our own naming conven-
tion, tailored to the specific types of parameters and files 
used in decision analytic modeling, in Table 2. In our nam-
ing convention, file names begin with the component num-
ber followed by some content descriptor, separated by under-
scores. User-defined functions are named starting with an 
action, followed by a descriptor, separated by underscores.
Our variable naming conventions involve encoding cer-
tain features of the variable in the name. The suggested 
naming structure would be <x>_<y>_<var_name>, where 
x indicates the data type (e.g., scalar, vector, matrix, data 
frame, etc.), y is the variable type (e.g., probability, rate, rel-
ative risk, cost, utility, etc.), and var_name is some descrip-
tion of the variable presented separated by underscores. Sug-
gested prefixes are summarized in Table 3.
2.4  Unit Testing
A full decision-analytic model, complete with all the mod-
ules outlined in the DARTH framework, will have complex 
interdependence between the various functions and pro-
cesses. It is important to ensure that these functions behave 
as expected to maintain the integrity of the project. Thus, 
systematic testing is recommended alongside the develop-
ment of the decision analysis source code. Testing increases 
confidence in the results and conclusions of the model and 
associated analyses and also allows the analyst to quickly 
identify whether modifications or additions to the analysis 
code impacts the behavior of the previously developed func-
tions and processes [35]. A widely used testing method is 
unit testing, which tests a unit of code (often a function or 
a small process) to verify whether the code executes and 
generates outputs as intended.
For a comprehensive decision-analytic project, we sug-
gest writing tests alongside the development of any new 
function or process or whenever a bug is found [30, 35]. This 
practice results in a high level of test coverage of the analysis 
code, reducing the likelihood that unintended interactions or 
incompatibilities between functions and/or processes will 
go undetected. In practice, we suggest that each R script in 
the ‘R’ folder have a corresponding testing ‘.R’ script in a 
separate ‘tests’ folder. The naming of a test file could begin 
with ‘test_’, followed by the file name of the source code that 
is the target of the testing. This file structure is also compat-
ible with the R package structure.
In each test file, tests are organized by the functions or 
processes to be tested. A single function or process will 
likely be associated with multiple tests. For instance, unit 
testing of a function will involve testing that the function 
runs when inputs are of the right data type, that the func-
tion outputs are of the right data type, and that the function 
outputs are correct in dimension and value for specific sets 
of input values. It is also important to test the error check-
ing within a function, such that the function returns an error 
when invalid inputs are provided or unexpected results are 
found.
Comprehensive testing facilitates model sharing, as any 
downstream user wishing to modify the code can easily 
verify whether their changes to the original source code 
require adjustments to be made to other parts of the code. 
To illustrate the use of unit testing, we provided examples 
of unit testing on two selected source code files in our case 
study using the R package testthat [30, 36]. We only include 
a small number of tests so as to not overwhelm those new 
to testing; however, in practice, a comprehensive set of unit 
tests should be included.
Table 2  File and variable naming conventions in the proposed 
DARTH coding framework
Object type Naming recommendation Examples
Files dir/<component 
number>_<description> 
.<ext>
analysis/01_model_
inputs.R
R/02_simulation_
model_functions.R
Functions <action!>_<description> generate_init_params()
generate_psa_params()
Variables <x>_<y>_<var_name>
where
x = data type prefix
y = variable type prefix
var_name = brief descriptor
n_samp
hr_S1D
v_r_mort_by_age
a_M
l_params_all
df_out_ce
Table 3  Recommended prefixes in variable names that encode data 
and variable type
QALYs quality-adjusted life-years
Prefix Data type Prefix Variable type
<> (no prefix) scalar n Number
v vector p Probability
m matrix r Rate
a array u Utility
df data frame c Cost
dtb data table hr Hazard ratio
l list rr Relative risk
ly Life years
q QALYs
se Standard error
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2.5  Additional Tools to Support Model 
Transparency
A number of tools exist that can facilitate the decision mod-
elers interaction with the R language. A useful and com-
monly used tool is RStudio, an open-source, integrated 
development environment (IDE) for R. RStudio offers 
functionality that facilitates R coding (e.g., syntax highlight-
ing). With RStudio it is possible to create projects, which 
are files with the ‘.Rproj’ extension. An RStudio project 
creates a specific R session for the DARTH framework with 
its own working directory, workspace, history, and source 
documents [41]. In other words, the RStudio project makes 
a standalone working environment without the trouble of 
having to specify where files are located when used in differ-
ent computers. Additional functionality is embedded within 
the RStudio platform that allows the modeler to present the 
output of the analysis in a visually attractive and dynamic 
form. In particular, through the Shiny package, an interac-
tive web app [37] can be developed to facilitate the usage of 
the decision model [38]. The Shiny app allows the user to 
modify the input parameters, rerun the model through the 
app’s interface, and navigate through the updated results. 
Although Shiny has been developed to support web access 
to R models, it can also be downloaded and run locally. We 
have added the ‘Shiny_framework.R’ file that generates the 
Shiny app in the GitHub repository, which can be executed 
locally once the darthpack repository is either down-
loaded or installed. An additional advantage of having the 
DARTH framework as an R package via darthpack is its 
integration with other packages to develop web applications 
with JavaScript, such as OpenCPU.
Once the analysis is completed, the user might be inter-
ested in generating a report of the findings. R Markdown is 
a functionality within RStudio that provides a dynamic solu-
tion to developing reports within an R environment. Once 
written, an R Markdown file can be ‘knitted’ (transcribed) 
to a variety of different formats (.docx, .pdf, .html). There 
are a number of advantages associated with the use of R 
Markdown. The primary one is the integration of the report-
writing process with the data analysis or the simulation 
modeling. This allows for a better documented model-based 
CEA and a dynamic element to the report. For example, a 
report could be built in R Markdown while allowing for 
narrative that can be automatically updated conditional on 
the findings of the analysis. Another advantage of R Mark-
down is the ease of making a report publicly accessible, 
because the ability for documents to be knitted in differ-
ent web formats allows them to be easily published on the 
web. With R Markdown, the description and reporting of 
the workflow of a CEA can be made more efficient with 
limited entry costs for those not already familiar with this 
functionality. Recently developed packages further enhance 
the functionality of R Markdown. For example, bookdown 
facilitates the development of long reports [39]. We provide 
an example of how a report could be written in R Markdown 
with bookdown by describing the use of the functions of 
all the components of the DARTH framework using the case 
study described below.
2.6  Case Study: Sick–Sicker Model
To showcase the DARTH framework, we performed a CEA 
of a hypothetical treatment using a state-transition cohort 
model on a hypothetical disease. For this CEA, we used the 
previously published Sick–Sicker model first described by 
Enns et al. [40]. Briefly, the Sick–Sicker model simulates 
a hypothetical cohort of 25-year-old healthy individuals 
with an age-specific background mortality that are at risk 
of developing a disease with two different stages of illness, 
‘Sick’ (S1) and ‘Sicker’ (S2). Individuals in both the S1 and 
S2 states face an increased mortality and reduced quality of 
life (QoL) compared with healthy individuals. The hypo-
thetical treatment improves QoL for individuals in the S1 
state but has no effect on the QoL of those in the S2 state. 
While individuals who are afflicted with the illness can be 
identified through obvious symptoms, those in S1 cannot be 
easily distinguished from those in the S2 state. Thus, under 
the treatment strategy, all afflicted individuals are treated and 
accrue the costs of treatment, even though only those in S1 
experience any benefit.
We assume that most parameters of the Sick–Sicker 
model and their uncertainty are known to the analyst and 
do not require any statistical estimation. However, because 
we cannot distinguish between S1 and S2, neither state-
specific mortality hazard ratios nor the probability of pro-
gressing from S1 to S2 can be directly estimated. Therefore, 
we estimated these parameters by calibrating the model to 
epidemiological data. We internally validated the calibrated 
model by comparing the predicted outputs from the model, 
evaluated at the calibrated parameters, against the calibra-
tion targets.
As part of the CEA, we conducted different deterministic 
sensitivity analyses, including one-way and two-way sensi-
tivity analyses. To quantify the effect of parameter uncer-
tainty on decision uncertainty, we conducted a PSA and 
reported our uncertainty analysis results with incremental 
costs and QALYs, ICERs, CEACs, CEAF, and ELCs [26]. 
We also conducted a VOI analysis to determine whether 
potential future research is needed to reduce parameter 
uncertainty.
The CEA of the Sick–Sicker model implemented in the 
DARTH framework may be downloaded from GitHub (https 
://githu b.com/DARTH -git/darth pack). We recommend either 
using the repository of this framework as a GitHub template 
or installing it as an R package. Using darthpack as a 
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template allows users to easily modify any of the included 
files and is most appropriate for users wishing to adapt the 
DARTH framework to their own application model and 
analyses. To use darthpack as a template, users should 
first either clone the repository to their GitHub account or 
download it locally as a .zip file containing all files and 
folders. For users simply wishing to reproduce the exist-
ing analyses of the Sick-Sicker model in darthpack or 
conduct simple explorations using the included model and/
or analysis functions, installing darthpack as a package 
is most appropriate. To install darthpack as a package, 
users should make use of the devtools package by typ-
ing devtools::install_github(“DARTH-git/
darthpack”). Detailed instructions on how to use and 
install the repository can be found on the darthpack web-
site (https ://darth -git.githu b.io/darth pack/).
The DARTH framework is divided into different fold-
ers, described in Table 1, that could be accessed from the 
RStudio project ‘darthpack.Rproj’. A detailed description 
on how to install and use the DARTH framework on the 
Sick–Sicker mode can be found in the darthpack GitHub 
repository (https ://githu b.com/DARTH -git/darth pack) and 
website (https ://darth -git.githu b.io/darth pack). The frame-
work of the case study is considered a finalized CEA so each 
of the components in the ‘analysis’ folder should be able to 
run independently from the rest of them. For example, if 
there is interest in reproducing the calibration component, 
the analyst or reviewer of the CEA can start by running the 
file ‘03_calibration.R’ in the ‘analysis’ folder, and so on. 
To reproduce the entire CEA, including all model devel-
opment components and all analyses, the analyst should 
run the ‘_master.R’ file in the ‘analysis’ folder, which will 
execute the R scripts of each of the components. For a more 
detailed description of how the elements (functions, data, 
and procedures) are interconnected within and between 
components for the Sick–Sicker model CEA case study, we 
recommend reading the vignettes of darthpack stored in 
the ‘vignettes’ folder of the repository. In addition, a detailed 
description of the CEA of the Sick–Sicker model can be 
found in the file ‘report.pdf’ stored in the ‘report/_book’ 
folder and attached as electronic supplementary material to 
this manuscript. This report could be used as a template for 
CEAs that are submitted to HTA agencies for their approval. 
These documents describe the code in detail and will guide 
the reader on how to run code of the Sick–Sicker model 
implemented in the DARTH framework.
3  Discussion
We developed the DARTH framework as a way to support 
transparency, reproducibility, and model sharing in R-based 
decision analytic models and CEAs. Adoption of this general 
framework will facilitate the sharing and readability of deci-
sion analytic models implemented in R as analysts adopting 
the framework will be familiar with the component structure 
and the specific choices and assumptions of each component 
can be easily scrutinized. The standardization of R code pre-
sented here may also support the broader use of R in formal 
HTA submissions, allowing for more complex modeling 
methods to be more transparently incorporated into deci-
sion making regarding coverage of new health technologies.
As we illustrated in this paper, a traditional model-based 
decision analysis follows a well-defined conceptual struc-
ture. Despite this, our field lacks practical guidance for 
the implementation of decision modeling in programming 
languages. The DARTH framework addresses this gap and 
will facilitate overall improvement in the quality, transpar-
ency, and reproducibility of decision models and analyses 
conducted in R. Frameworks like the one we propose have 
been adopted in other fields such as engineering, mathemat-
ics, and computer science to routinize frequently conducted 
analyses, leading to improvements in quality and efficiency 
in these methods [42]. There are additional benefits of using 
R as the platform to develop model-based CEA. One such 
benefit is that R has established packages that allow the eval-
uation of functions in parallel using different cores of com-
puting systems. If components have processes that require 
the evaluation of the model multiple times (e.g., calibration, 
validation, or PSA), the model evaluations can be carried out 
more efficiently by parallelizing these processes.
While a standardized framework can facilitate model 
sharing and readability, it must still be flexible enough to 
accommodate a wide variety of needs and applications. The 
framework we describe here is meant merely as the scaf-
folding for any given analysis; ultimately, the analyst should 
make design decisions that work for their particular use and 
that facilitate transparency to their audience, be it clients, 
stakeholders, a government agency, other academics, or the 
general public. Alongside the details of the DARTH frame-
work, we have also attempted to provide the rationale behind 
our recommendations so that analysts may adapt the specific 
structures and recommendations to their needs while follow-
ing the spirit of the framework.
The DARTH framework is focused on the structure 
and organization of the source code underlying a decision 
model and analysis to support transparency and sharing. The 
DARTH framework facilitates dissemination by organizing 
all the code necessary to conduct a given set of analyses into 
a single directory that can be easily shared via a repository 
hosting service, such as GitHub, as we have done in our 
example model, or through open-source initiatives, such as 
the Open-Source Model Clearinghouse [7]. The DARTH 
framework is built as an R package, which allows the model 
and analysis source code to be loaded directly into R. For a 
description of the steps involved in package development, 
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see the R package book by Wickham [30]. A package has the 
advantage of generating a self-contained collection of code 
with explicit dependencies on other packages and versions 
with a standard downloading and installation process for 
users. A package is also advantageous if computationally 
intensive functions have been compiled from C/C++ source 
code, as these functions will be available to the user as R 
functions. The C/C++ source code can be stored in a folder 
named ‘src’ as part of an R package.
An R package makes it easier for others to use built-in 
functions, say for running a model with different input val-
ues or exactly reproducing the results of a set of pre-defined 
analyses. To modify the model structure or adapt it to a new 
application, the corresponding functions need to be modified 
and the package must be recompiled. This may be cumber-
some in a model-development phase, when debugging and 
internal validation studies are being conducted. However, if 
RStudio is used for the package development or adaptation, 
compiling the package is an effortless task as long as all the 
R code is sound and well implemented. If an analyst truly 
wants their model to be broadly used by practitioners, tools 
such as R Shiny can make interacting with models more 
user-friendly. Documenting the model structure and different 
components in the CEA using R documentation and R Mark-
down also enhances the transparency of the decision models 
and associated analyses. The use of the DARTH framework 
alongside these complementary dissemination tools are the 
foundations for open, transparent, and reproducible decision 
modeling, paving the way to an ideal, open-source world.
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